Efficacy of PRP for bone fusion in LLIF
- Conditions
- vertebral fracture, lumbar canal stenosis, lumbar spondylolisthesis, adult spine deformity
- Registration Number
- JPRN-jRCTb032200199
- Lead Sponsor
- Yamazaki Masashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
1. Patients who receives lateral lumbar interbody fusion surgery for vertebral fracture, lumbar canal stenosis, lumbar spondylolisthesis, adult spine deformity, and so on
2. Patients who receives lateral lumbar interbody fusion surgery at 1-4 levels
3. Patients over 20 years old
4. Patients with informed concent and understanding for treatment
1. Patients with a history of lumbar surgery, purulent spondylitis, or spinal tumor
2. Patients who received other Investigational new drug within 3 months of participating in this clinical study
3. Patients who have a primary illness that is clearly inferior to bone formation (bone metabolic disease, dialysis, and so on)
4. Patients who have uncontrolled diabetes
5. Patients with anemia (Hb<9.0g/dL)
6. Patients who have disorder of blood coagulation.
7. Patients with rheumatoid arthritis who are using biologics with high risk of perioperative infection.
8. Women who are pregnant or suspected ofbeing pregnant or breastfeeding
9. Patients with metal allergy
10. Patients who needs the legal representative
11. Patients who are judged inappropriate by the responsible doctor for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method